Research ExplorerScientific StaffClaudia Langebrake

Priv.-Doz. Dr. rer. medic. ID: 27655

Claudia Langebrake

graph of relations
Affiliations
ORCID: 0000-0003-1249-4223

Publications

7. Ringversuch Arzneimittelinformation der ADKA

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

Chimeric antigen receptor T-cell therapy and fludarabine precision dosing imperatives

Research output: SCORING: Contribution to journal › Comment/debate › Research

Implementierung und operatives Management zugelassener CAR-T-Zelltherapien: Ein Leitfaden der GoCART Coalition Pharmacist Working Group

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

A Unified Data Architecture for Assessing Motor Symptoms in Parkinson's Disease

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Medication errors in cancer therapy: Reports from German hospital pharmacists between 2008 and 2019

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Development of an immediate release excipient composition for 3D printing via direct powder extrusion in a hospital

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Clinical pharmacy services in critical care: results of an observational study comparing ward-based with remote pharmacy services

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Role and competencies of the EBMT clinical pharmacists and clinical pharmacologists: a pan-European survey

Research output: SCORING: Contribution to journal › Letter › Research › peer-review

Individualized busulfan dosing improves outcomes compared to fixed-dose administration in pre-transplant minimal residual disease-positive acute myeloid leukemia patients with intermediate-risk undergoing allogeneic stem cell transplantation in CR

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (70)